- •Intended Audience
- •1.1 Financing the Firm
- •1.2Public and Private Sources of Capital
- •1.3The Environment forRaising Capital in the United States
- •Investment Banks
- •1.4Raising Capital in International Markets
- •1.5MajorFinancial Markets outside the United States
- •1.6Trends in Raising Capital
- •Innovative Instruments
- •2.1Bank Loans
- •2.2Leases
- •2.3Commercial Paper
- •2.4Corporate Bonds
- •2.5More Exotic Securities
- •2.6Raising Debt Capital in the Euromarkets
- •2.7Primary and Secondary Markets forDebt
- •2.8Bond Prices, Yields to Maturity, and Bond Market Conventions
- •2.9Summary and Conclusions
- •3.1Types of Equity Securities
- •Volume of Financing with Different Equity Instruments
- •3.2Who Owns u.S. Equities?
- •3.3The Globalization of Equity Markets
- •3.4Secondary Markets forEquity
- •International Secondary Markets for Equity
- •3.5Equity Market Informational Efficiency and Capital Allocation
- •3.7The Decision to Issue Shares Publicly
- •3.8Stock Returns Associated with ipOs of Common Equity
- •Ipo Underpricing of u.S. Stocks
- •4.1Portfolio Weights
- •4.2Portfolio Returns
- •4.3Expected Portfolio Returns
- •4.4Variances and Standard Deviations
- •4.5Covariances and Correlations
- •4.6Variances of Portfolios and Covariances between Portfolios
- •Variances for Two-Stock Portfolios
- •4.7The Mean-Standard Deviation Diagram
- •4.8Interpreting the Covariance as a Marginal Variance
- •Increasing a Stock Position Financed by Reducing orSelling Short the Position in
- •Increasing a Stock Position Financed by Reducing orShorting a Position in a
- •4.9Finding the Minimum Variance Portfolio
- •Identifying the Minimum Variance Portfolio of Two Stocks
- •Identifying the Minimum Variance Portfolio of Many Stocks
- •Investment Applications of Mean-Variance Analysis and the capm
- •5.2The Essentials of Mean-Variance Analysis
- •5.3The Efficient Frontierand Two-Fund Separation
- •5.4The Tangency Portfolio and Optimal Investment
- •Identification of the Tangency Portfolio
- •5.5Finding the Efficient Frontierof Risky Assets
- •5.6How Useful Is Mean-Variance Analysis forFinding
- •5.8The Capital Asset Pricing Model
- •Implications for Optimal Investment
- •5.9Estimating Betas, Risk-Free Returns, Risk Premiums,
- •Improving the Beta Estimated from Regression
- •Identifying the Market Portfolio
- •5.10Empirical Tests of the Capital Asset Pricing Model
- •Is the Value-Weighted Market Index Mean-Variance Efficient?
- •Interpreting the capm’s Empirical Shortcomings
- •5.11 Summary and Conclusions
- •6.1The Market Model:The First FactorModel
- •6.2The Principle of Diversification
- •Insurance Analogies to Factor Risk and Firm-Specific Risk
- •6.3MultifactorModels
- •Interpreting Common Factors
- •6.5FactorBetas
- •6.6Using FactorModels to Compute Covariances and Variances
- •6.7FactorModels and Tracking Portfolios
- •6.8Pure FactorPortfolios
- •6.9Tracking and Arbitrage
- •6.10No Arbitrage and Pricing: The Arbitrage Pricing Theory
- •Verifying the Existence of Arbitrage
- •Violations of the aptEquation fora Small Set of Stocks Do Not Imply Arbitrage.
- •Violations of the aptEquation by Large Numbers of Stocks Imply Arbitrage.
- •6.11Estimating FactorRisk Premiums and FactorBetas
- •6.12Empirical Tests of the Arbitrage Pricing Theory
- •6.13 Summary and Conclusions
- •7.1Examples of Derivatives
- •7.2The Basics of Derivatives Pricing
- •7.3Binomial Pricing Models
- •7.4Multiperiod Binomial Valuation
- •7.5Valuation Techniques in the Financial Services Industry
- •7.6Market Frictions and Lessons from the Fate of Long-Term
- •7.7Summary and Conclusions
- •8.1ADescription of Options and Options Markets
- •8.2Option Expiration
- •8.3Put-Call Parity
- •Insured Portfolio
- •8.4Binomial Valuation of European Options
- •8.5Binomial Valuation of American Options
- •Valuing American Options on Dividend-Paying Stocks
- •8.6Black-Scholes Valuation
- •8.7Estimating Volatility
- •Volatility
- •8.8Black-Scholes Price Sensitivity to Stock Price, Volatility,
- •Interest Rates, and Expiration Time
- •8.9Valuing Options on More Complex Assets
- •Implied volatility
- •8.11 Summary and Conclusions
- •9.1 Cash Flows ofReal Assets
- •9.2Using Discount Rates to Obtain Present Values
- •Value Additivity and Present Values of Cash Flow Streams
- •Inflation
- •9.3Summary and Conclusions
- •10.1Cash Flows
- •10.2Net Present Value
- •Implications of Value Additivity When Evaluating Mutually Exclusive Projects.
- •10.3Economic Value Added (eva)
- •10.5Evaluating Real Investments with the Internal Rate of Return
- •Intuition for the irrMethod
- •10.7 Summary and Conclusions
- •10A.1Term Structure Varieties
- •10A.2Spot Rates, Annuity Rates, and ParRates
- •11.1Tracking Portfolios and Real Asset Valuation
- •Implementing the Tracking Portfolio Approach
- •11.2The Risk-Adjusted Discount Rate Method
- •11.3The Effect of Leverage on Comparisons
- •11.4Implementing the Risk-Adjusted Discount Rate Formula with
- •11.5Pitfalls in Using the Comparison Method
- •11.6Estimating Beta from Scenarios: The Certainty Equivalent Method
- •Identifying the Certainty Equivalent from Models of Risk and Return
- •11.7Obtaining Certainty Equivalents with Risk-Free Scenarios
- •Implementing the Risk-Free Scenario Method in a Multiperiod Setting
- •11.8Computing Certainty Equivalents from Prices in Financial Markets
- •11.9Summary and Conclusions
- •11A.1Estimation Errorand Denominator-Based Biases in Present Value
- •11A.2Geometric versus Arithmetic Means and the Compounding-Based Bias
- •12.2Valuing Strategic Options with the Real Options Methodology
- •Valuing a Mine with No Strategic Options
- •Valuing a Mine with an Abandonment Option
- •Valuing Vacant Land
- •Valuing the Option to Delay the Start of a Manufacturing Project
- •Valuing the Option to Expand Capacity
- •Valuing Flexibility in Production Technology: The Advantage of Being Different
- •12.3The Ratio Comparison Approach
- •12.4The Competitive Analysis Approach
- •12.5When to Use the Different Approaches
- •Valuing Asset Classes versus Specific Assets
- •12.6Summary and Conclusions
- •13.1Corporate Taxes and the Evaluation of Equity-Financed
- •Identifying the Unlevered Cost of Capital
- •13.2The Adjusted Present Value Method
- •Valuing a Business with the wacc Method When a Debt Tax Shield Exists
- •Investments
- •IsWrong
- •Valuing Cash Flow to Equity Holders
- •13.5Summary and Conclusions
- •14.1The Modigliani-MillerTheorem
- •IsFalse
- •14.2How an Individual InvestorCan “Undo” a Firm’s Capital
- •14.3How Risky Debt Affects the Modigliani-MillerTheorem
- •14.4How Corporate Taxes Affect the Capital Structure Choice
- •14.6Taxes and Preferred Stock
- •14.7Taxes and Municipal Bonds
- •14.8The Effect of Inflation on the Tax Gain from Leverage
- •14.10Are There Tax Advantages to Leasing?
- •14.11Summary and Conclusions
- •15.1How Much of u.S. Corporate Earnings Is Distributed to Shareholders?Aggregate Share Repurchases and Dividends
- •15.2Distribution Policy in Frictionless Markets
- •15.3The Effect of Taxes and Transaction Costs on Distribution Policy
- •15.4How Dividend Policy Affects Expected Stock Returns
- •15.5How Dividend Taxes Affect Financing and Investment Choices
- •15.6Personal Taxes, Payout Policy, and Capital Structure
- •15.7Summary and Conclusions
- •16.1Bankruptcy
- •16.3How Chapter11 Bankruptcy Mitigates Debt Holder–Equity HolderIncentive Problems
- •16.4How Can Firms Minimize Debt Holder–Equity Holder
- •Incentive Problems?
- •17.1The StakeholderTheory of Capital Structure
- •17.2The Benefits of Financial Distress with Committed Stakeholders
- •17.3Capital Structure and Competitive Strategy
- •17.4Dynamic Capital Structure Considerations
- •17.6 Summary and Conclusions
- •18.1The Separation of Ownership and Control
- •18.2Management Shareholdings and Market Value
- •18.3How Management Control Distorts Investment Decisions
- •18.4Capital Structure and Managerial Control
- •Investment Strategy?
- •18.5Executive Compensation
- •Is Executive Pay Closely Tied to Performance?
- •Is Executive Compensation Tied to Relative Performance?
- •19.1Management Incentives When Managers Have BetterInformation
- •19.2Earnings Manipulation
- •Incentives to Increase or Decrease Accounting Earnings
- •19.4The Information Content of Dividend and Share Repurchase
- •19.5The Information Content of the Debt-Equity Choice
- •19.6Empirical Evidence
- •19.7Summary and Conclusions
- •20.1AHistory of Mergers and Acquisitions
- •20.2Types of Mergers and Acquisitions
- •20.3 Recent Trends in TakeoverActivity
- •20.4Sources of TakeoverGains
- •Is an Acquisition Required to Realize Tax Gains, Operating Synergies,
- •Incentive Gains, or Diversification?
- •20.5The Disadvantages of Mergers and Acquisitions
- •20.7Empirical Evidence on the Gains from Leveraged Buyouts (lbOs)
- •20.8 Valuing Acquisitions
- •Valuing Synergies
- •20.9Financing Acquisitions
- •Information Effects from the Financing of a Merger or an Acquisition
- •20.10Bidding Strategies in Hostile Takeovers
- •20.11Management Defenses
- •20.12Summary and Conclusions
- •21.1Risk Management and the Modigliani-MillerTheorem
- •Implications of the Modigliani-Miller Theorem for Hedging
- •21.2Why Do Firms Hedge?
- •21.4How Should Companies Organize TheirHedging Activities?
- •21.8Foreign Exchange Risk Management
- •Indonesia
- •21.9Which Firms Hedge? The Empirical Evidence
- •21.10Summary and Conclusions
- •22.1Measuring Risk Exposure
- •Volatility as a Measure of Risk Exposure
- •Value at Risk as a Measure of Risk Exposure
- •22.2Hedging Short-Term Commitments with Maturity-Matched
- •Value at
- •22.3Hedging Short-Term Commitments with Maturity-Matched
- •22.4Hedging and Convenience Yields
- •22.5Hedging Long-Dated Commitments with Short-Maturing FuturesorForward Contracts
- •Intuition for Hedging with a Maturity Mismatch in the Presence of a Constant Convenience Yield
- •22.6Hedging with Swaps
- •22.7Hedging with Options
- •22.8Factor-Based Hedging
- •Instruments
- •22.10Minimum Variance Portfolios and Mean-Variance Analysis
- •22.11Summary and Conclusions
- •23Risk Management
- •23.2Duration
- •23.4Immunization
- •Immunization Using dv01
- •Immunization and Large Changes in Interest Rates
- •23.5Convexity
- •23.6Interest Rate Hedging When the Term Structure Is Not Flat
- •23.7Summary and Conclusions
- •Interest Rate
- •Interest Rate
23.4Immunization
Immunizationis a technique for locking in the value of a portfolio at the end of a plan-
ning horizon. In a sense, immunization turns a portfolio into a zero-coupon bond.
Ordinary Immunization
Immunization was developed by F. M. Redington, an actuary, who showed that if the
durations and market values of the assets and liabilities of a financial institution were
equal, the equity of the institution would be insensitive to movements in interest rates.11
We generalize this result here, allowing the ratios of the durations of the assets and lia-
bilities to be inversely proportional to their market value ratios.
Applying Immunization Techniques to Stabilize the Future Value of a Bond
Portfolio.Immunization techniques can be applied to reduce the interest rate sensi-
tivity of the equity of financial institutions or the equity stake of a corporation in a
defined benefit pension plan.12Today, however, immunization techniques are more
often used to stabilize the value of a bond portfolio at the horizon date, which is the
date at the end of some planning horizon.
For simplicity, assume that the term structure of interest rates is flat. In this case,
the fundamental rule for immunizing a portfolio is to match the duration of the port-
folio with the horizon date. For example, a manager with a horizon date of January 1,
2010, should, on January 1, 2004, have a portfolio duration of 6 years; on January 1,
2005, the portfolio duration should be 5 years; on June 30, 2008, it should be 1.5 years.
To implement the immunization strategy, it is important that all coupons, principal
payments, and other cash distributions received be reinvested in the portfolio. Main-
taining a duration that is matched to the horizon date means that the rate at which these
cash distributions are reinvested exactly offsets the gain or loss in the value of the port-
folio as interest rates change.
Why Immunization Locks in a Value at the Horizon Date.To see why this strat-
egy locks in the portfolio value at the horizon date, compare theportfolio with a zero-
coupon bond of identical market value which has a maturity, and hence a duration, equal
to the duration of the immunized portfolio. Along position in the portfolio and a short
position in the zero-coupon bond has both a market value and a duration of zero.
When the duration of the combined long and short position is zero, its sensitivity
to interest rate movements and hence its volatility is zero. For a brief instant, it is risk-
less. As time elapses, keeping it riskless requires adjusting the long position in the port-
folio to have the same duration as the maturity of the zero-coupon bond by shortening
the duration of the long position over time in order to maintain a duration of zero for
the combination of the immunized portfolio (the long position) and the short position
in the zero-coupon bond.
11
See Redington (1952).
12See
Example 23.9.
Grinblatt |
VI. Risk Management |
23. Interest Rate Risk |
©
The McGraw |
Markets and Corporate |
|
Management |
Companies, 2002 |
Strategy, Second Edition |
|
|
|
-
Chapter 23
Interest Rate Risk Management
835
Since riskless self-financing investments do not appreciate or depreciate in value,
the riskless self-financing combination of the immunized bond portfolio and the short
position in the zero-coupon bond—if the former is properly updated over time—will
have a value of zero at the maturity date of the zero-coupon bond. At the maturity date,
this means that the immunized portfolio has to have a market value equal to the face
value (and market value) of the zero-coupon bond.
Result 23.5 summarizes this procedure.
-
Result 23.5
If the term structure of interest rates is flat, immunization “guarantees” a fixed value for animmunized portfolio at a horizon date. The value obtained is the same as the face value ofa zero-coupon bond with (1) the same market value as the original portfolio and (2) a matu-rity date equal to the horizon date selected as the target date to which the duration of theimmunized portfolio is fixed.
Viewing the portfolio to be immunized as an asset, and the zero-coupon bond as
a liability, we have done exactly what Redington suggested for financial institutions—
matching the durations of assets and liabilities with the same market value. Of course,
the zero-coupon bond was not actually sold short in order to immunize the portfolio.
Rather, we merely pretended to sell short a zero-coupon bond to help clarify what to
do to the portfolio to ensure a value at the horizon date.
Example 23.10 shows how to calculate the lock-in value at the horizon date.
Example 23.10:Computing the Lock-In Amount at Some Horizon Date
The current yield to maturity is 8 percent compounded semiannually for bonds of all matu-
rities.A bond portfolio consists of $10 million (market value) of fixed-income securities.What
amount will the portfolio manager be able to lock in three years from now?
Answer:The current market value of the portfolio is $10 million.At 8 percent, the future
value of the portfolio in three years is
1.046
$10 million $12.653 million
Example 23.11 shows how to alter a portfolio to lock in its value.
Example 23.11:Using Immunization Techniques to Lock In a Payoff
The $10 million portfolio in Example 23.10 is a pension portfolio, which currently has a dura-
tion of five years.Half the portfolio’s market value consists of identical maturity zero-coupon
bonds.The remainder consists of $5 million (market value) of the 2-year straight-coupon
bonds from Example 23.6.These bonds have a duration of 1.89 years and an 8 percent
yield, compounded semiannually.
a.What is the maturity of the zero-coupon bonds in the portfolio?
b.How should the manager rebalance the portfolio between the 2-year straight-coupon
bonds and the zero-coupon bonds to immunize it at a 3-year horizon date?
Answer:a.The zero-coupon bonds have to have a maturity of 8.11 years because this
is the only maturity that makes an equal-weighted average of the 2-year bonds’duration
(1.89) and the zero-coupon bonds’duration equal five years.
b.To immunize the portfolio for a horizon of three years, the duration of the portfolio has
to be changed to three years.Find weights xand 1xthat make the weighted average of
the durations
x(1.89) (1 x)8.11 3
The approximate solution is x .82154.Hence, $8.2154 million of the 2-year straight coupon
bonds must be owned, which requires an additional purchase of $3.2154 million (face and
-
Grinblatt
1682 Titman: FinancialVI. Risk Management
23. Interest Rate Risk
© The McGraw
1682 HillMarkets and Corporate
Management
Companies, 2002
Strategy, Second Edition
836Part VIRisk Management
market value) of these bonds.To finance the purchase, sell $3.2154 million (market value)
of the zero-coupon bonds, which have an aggregate face value of about
$6.07 million $3.2154 million (1.04)16.22
Example 23.11 described what the portfolio manager must do currently to immu-
nize his portfolio for a horizon of three years. However, this manager cannot rest on
his laurels. Every day, as time elapses and interest rates change, the immunized port-
folio becomes nonimmunized if the manager acts passively. To maintain the immu-
nization, as Example 23.12 illustrates, it is important to constantly update the weight-
ing of the zero-coupon bonds and the 2-year straight-coupon bonds.
Example 23.12:Updating Portfolio Weights in an Immunized Portfolio
What must the portfolio manager do in the future to immunize the portfolio, particularly at
the maturity date of the 2-year straight-coupon bonds?
Answer:As each day elapses, the portfolio manager must shorten the duration by one
day.Some of this shortening will happen even if the manager does nothing, since the dura-
tion of both bond types is diminishing as time elapses.However, it is unlikely that this nat-
ural shortening of duration will be exactly one day.Hence, the manager must recompute
duration periodically for the new interest rate and the time to payment of the cash flows and
adjust duration accordingly.This creates a problem after two years has elapsed.At that point,
the manager would like the portfolio to have a 1-year duration, but would have only zero-
coupon bonds maturing in 6.11 years (and a duration of 6.11 years) once the straight-coupon
bonds mature.This implies that the manager must begin to use a third security in the port-
folio as the maturity date of the straight-coupon bonds nears.
The immunization strategy employed in Examples 23.10–23.12 was equivalent to
designing a hypothetical portfolio with a duration of zero. This portfolio consists of the
2-year straight-coupon bonds, 8.11-year zero coupon bonds, and a short position in
3-year zero-coupon bonds that finances the other two positions. If this hypothetical port-
folio is managed so that it has a value of zero at the horizon date, the original immu-
nized portfolio is managed so that it has a value equal to that of 3-year zero-coupon
bonds with an aggregate face value of $12.653 million.
The same insight can be used to understand Redington’s result as it applies to finan-
cial institutions. If the assets and liabilities of the financial institution have unequal
value, construct fictitious zero-coupon bonds with a market value equal to the market
value of the institution’s equity (assets minus liabilities) and a maturity equal to the
horizon date at which the equity’s value needs to be guaranteed. To immunize the equity
in this fashion over time, manage a self-financing investment that is long the assets,
short the liabilities, and short the zero-coupon bonds, so that it maintains zero dura-
tion. This is equivalent to structuring the assets and liabilities of the institution so that
they have a duration equal to the maturity of the zero-coupon bonds,13as Example
23.13 illustrates for a savings bank.
13The
self-financing investment will continue to have a value of zero if the immunization procedure
is followed, implying that the assets less the liabilities (which equals the equity) will have a value equal
to the value of the fictitious zero-coupon bond.
Grinblatt |
VI. Risk Management |
23. Interest Rate Risk |
©
The McGraw |
Markets and Corporate |
|
Management |
Companies, 2002 |
Strategy, Second Edition |
|
|
|
-
Chapter 23
Interest Rate Risk Management
837
Example 23.13:Using Immunization to Manage Savings Bank Assets
The assets of a savings bank consist of mortgages with a 4-year duration and a present value
of $10 billion.The bank’s liabilities consist of customer deposits and CDs with a duration of
two years and a present value of $5 billion.Interest rates are 8 percent, compounded annu-
ally at all maturities.Assume that the bank’s management wants to ensure that the bank has
a fixed amount of equity capital at the time the bank’s next regulatory examination is sched-
uled, in two years.
a.How much equity value can it guarantee at the time of the next regulatory examination?
b.Given that the savings bank can invest in commercial paper (which can be regarded
as a short-term zero-coupon bond with a 3-month maturity) and sell some or all of its
mortgage assets, what should the bank do to lock in an equity value two years from now?
Answer:a.The current $5 billion in equity can have a “lock-in”value in two years of
$5.832 billion [ (1.08)2$5 billion]
b.To lock in this value, adjust the duration of the equity to two years, and then continu-
ally shorten the duration by one day as each day elapses.The current duration of the equity
is a weighted average of the durations of the assets and liabilities.Since the assets are twice
as large as the liabilities, the asset weight must be 2 and the liability weight must be 1 for
the weights to sum to 1.This makes the current equity duration 2 (4 years) 1 (2 years)
6 years.To shorten this to two years by changing the asset portfolio, the bank should sell
some of the mortgage assets and buy commercial paper.This requires shortening the asset
duration to a duration (DUR) that satisfies
2DUR1 (2 years) 2 years
Thus, DUR 2 years.The market value of mortgage assets xand commercial paper assets
ythat have a duration of two years satisfy
4.25y
2
xy
The market values of the mortgage position xand of the commercial paper position y
mustsum to $10 billion, the current value of the bank’s assets.Thus, xand ymust also solve
xy $10 billion
Substituting this into the previous equation yields
4x.25($10 billionx)
2
$10 billion
This is solved by x $4.67 billion, implying y $5.33 billion.That is, sell $5.33 billion of
the $10 billion in mortgage assets and use the proceeds to buy 3-month commercial paper.
